Navigation Links
Iso-Insulin EIA Diabetes and Obesity Markers 008-10-1128-01

ProductsIso-Insulin EIA Diabetes and Obesity Markers 008-10-1128-01
Company ALPCO Diagnostics
Item Iso-Insulin EIA Diabetes and Obesity Markers 008-10-1128-01
Features 
Description Insulin is the principal hormone responsible for the control of glucose metabolism. It is synthesized in the b-cells of the islets of Langerhans as the precursor, proinsulin, which is processed to form C-peptide and insulin. Both are secreted in equimolar amounts into the portal circulation. The mature insulin molecule is comprised of two polypeptide chains, the A-chain and B-chain (21 and 30 amino acids, respectively). The two chains are linked together by two inter-chain disulphide bridges. There is also an intra-chain disulphide bridge in the A-chain. The ALPCO Iso-Insulin ELISA is a solid phase two-site enzyme immunoassay. It is based on the direct sandwich technique in which two monoclonal antibodies are directed against separate antigenic determinants on the human insulin molecule. During incubation, insulin in the sample reacts with peroxidase-conjugated anti-insulin antibodies and anti-insulin antibodies bound to the microplate wells. A simple washing step removes unbound enzyme labeled antibody. The bound conjugate is detected by reaction with 3,3',5,5'-tetramethylbenzidine (TMB). The reaction is stopped by adding acid. The colorimetric endpoint is read spectrophotometrically.
Info ALPCO DiagnosticsCall ALPCO Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-466-7731

Customer Service: (800) 592-5726
Web site: http://www.alpco.com

Related medicine products :

1. Iso-Insulin ELISA
2. Insulin Ultrasensitive EIA Diabetes and Obesity Markers 008-10-1132-01
3. Ultrasensitive C-Peptide EIA Diabetes and Obesity Markers 008-10-1141-01
4. Insulin EIA Diabetes and Obesity Markers 008-10-1113-01
5. C-Peptide EIA Diabetes and Obesity Markers 008-10-1136-01
6. Insulin Jumbo EIA Diabetes and Obesity Markers 008-10-1113-99
7. Ascensia Win Glucofacts Diabetes Management Software
8. Diabetes Partner PC (Patient Software)
9. Duet Diabetes Control System
10. Precision Xtra Advanced Diabetes Tester
11. Lyphochek Diabetes Control
Convex inner surface. Used in conjunction with the E5381 700 Circling Band (240 style). Indications: When high buckle is required. Outside diameter 31.7 mm....
Used in conjunction with the E5381 700 Circling Band (240 style). Indications: Narrow scleral bed. Overall length: 100 mm, 3.9 inches....
Used in conjunction with the E5381 600 Circling Band (40 style). Indications: When high buckle is required. Overall length: 14.0 mm....
Used with Single Tantalum Clip (E5381 854) and Double Tantalum Clip (E5381 853). Overall length: 7.2 mm....
Medicine Products:
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management ... levels in people with addiction who are served by MAP’s patient engagement ecosystem. ... device that monitors heart and breath rates to identify anxiety levels and can ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the ... 2-day program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish ... course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: an ... of God’s Work” is the creation of published author, Jerri Broglin, a survivor of ... , “I believe this a great eye-opener for those searching for answers, as we ...
(Date:4/24/2017)... ... ... Life of Purpose Treatment is proud to present “An Evening for Collegiate Recovery ... on May 10th at the University Auditorium. , This benefit concert, featuring Dr. Cheryl ... Collegiate Recovery Community (UFCRC). The concert will kick off the 5th Annual Southeastern CRC ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is a place where the ... my Art and Music. These are created as Metaphysical Transformations where music, which is ... culminate to the ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
Breaking Medicine Technology: